Market

Eli Lilly's $4.5B Medicine Foundry to Boost Drug Production by 2027
Management & Regulatory Eli Lilly's $4.5B Medicine Foundry to Boost Drug Production by 2027

Eli Lilly's continued advancements in pharmaceutical innovation and their commitment to escalating manufacturing capabilities encapsulate the core of the company's recent endeavors. At the heart of these developments is Eli Lilly’s extensive investment in research and development and the subsequent

Can LakeShore Biopharma Stock Overcome Its Recent Volatility?
Management & Regulatory Can LakeShore Biopharma Stock Overcome Its Recent Volatility?

LakeShore Biopharma Co Ltd. (NASDAQ: LSB) has attracted significant attention in the stock market due to its highly volatile performance over the past year. Investors have witnessed dramatic shifts in the company's stock price, reflecting a mixed sentiment among stakeholders about the firm's

Biopharma Industry Prioritizes Sustainability: Survey Insights and Challenges
Management & Regulatory Biopharma Industry Prioritizes Sustainability: Survey Insights and Challenges

The biopharmaceutical industry is increasingly recognizing sustainability as a critical component of its future success. According to Cytiva’s 2024 Global Biopharma Sustainability Review, which surveyed 800 industry professionals from 18 countries, sustainability has shifted from a secondary

Can Europe Overcome Challenges to Lead Biopharma Innovation Again?
Management & Regulatory Can Europe Overcome Challenges to Lead Biopharma Innovation Again?

Europe's rich heritage in pharmaceutical innovation has significantly shaped the global landscape. Yet, recent decades have seen this continent cede its leading position to the U.S. and witness emerging markets like China and India surge ahead. The question now is whether Europe can chart a path

Cryoport and SK pharmteco Join Forces to Advance Cell and Gene Therapy
Management & Regulatory Cryoport and SK pharmteco Join Forces to Advance Cell and Gene Therapy

In a significant move within the life sciences industry, Cryoport, Inc. and SK pharmteco have announced a strategic partnership focused on advancing cell and gene therapy. This collaboration aims to integrate logistics and manufacturing services for biotechnology and pharmaceutical companies,

How Is Sutro Biopharma Inc. Faring in the Current Market Climate?
Management & Regulatory How Is Sutro Biopharma Inc. Faring in the Current Market Climate?

Sutro Biopharma Inc. (NASDAQ: STRO) has experienced a dynamic market journey characterized by several key financial metrics, analyst ratings, and insider transactions. This article delves into the company’s recent market performance, aiming to provide investors with a comprehensive understanding of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later